Current Illinois CancerCare Clinical Trials

Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors

Study Number: URCC 18007

Study Summary:
This phase III trial studies how well bupropion works in reducing cancer related fatigue in stage I-III breast cancer survivors. Bupropion is a drug that is used to treat depression, as well as to help people quit smoking. Cancer and its treatment can cause fatigue. Giving bupropion may improve cancer related fatigue in breast cancer survivors.

Status: Open

Study Coordinator(s)
  • Courtney, 309-243-3660 cbrown@illinoiscancercare.com
  • Hannah S, 309-243-3603, hshearburn@illinoiscancercare.com
  • Kelsey, 309-243-3618 kfay@illinoiscancercare.com

Study Link

« Search Again